for MedicineCat.
SubCat.
Stack Card2012
FA2013
FA2014
FA
Microdeletions Cri Du Chat 94 89 91
Microdeletions Williams Syndrome 94 89 91
Trinucleotide Repeats Fragile X 92 87 89
Trinucleotide Repeats Friedreich's Ataxia 452 430 468
Trinucleotide Repeats Huntingtons Disease 90 417 454
Trinucleotide Repeats Myotonic Dystrophy 92 87 89
Trisomies Down Syndrome 93 88 90
Trisomies Edwards Syndrome 93 88 90
Trisomies Patau’s Syndrome 93 88 90
Enzyme Deficiencies Adenosine Deaminase Deficiency 70 66 68
Enzyme Deficiencies Alkaptonuria 112 108 111
Enzyme Deficiencies Classic Galactosemia 109 105 107
Enzyme Deficiencies Cystinuria 113 109 111
Enzyme Deficiencies Essential Fructosuria 108 104 106
Enzyme Deficiencies Fructose Intolerance 108 104 106
Enzyme Deficiencies G6PD Deficiency 108 104 106
Enzyme Deficiencies G6PD Mechanism 108 104 106
Enzyme Deficiencies Galactokinase Deficiency 109 105 107
Enzyme Deficiencies Hartnup Disease 113 109 527
Enzyme Deficiencies Homocystinuria 113 109 111
Enzyme Deficiencies Hyperammonenia 111 107 109
Enzyme Deficiencies Lesch-Nyhan Syndrome 70 66 58
Enzyme Deficiencies Maple Syrup Urine Disease 113 109 112
Enzyme Deficiencies Maternal Phenylketonuria 112 108 111
Enzyme Deficiencies Ornithine Transcarbamylase Deficiency 111 107 109
Enzyme Deficiencies Orotic Aciduria 69 65 384
Enzyme Deficiencies Phenylketonuria 112 108 111
Enzyme Deficiencies Pyruvate Dehydrogenase Deficiency 105 101 103
Glycogen Storage Diseases Cori's Disease 115 111 113
Glycogen Storage Diseases McArdles Disease 115 111 113
Glycogen Storage Diseases Pompe 115 111 113
Glycogen Storage Diseases Von Gierke's Disease 115 111 113
Lysosomal Storage Disorders Fabry’s Disease 116 112 114
Lysosomal Storage Disorders Gauchers Disease 116 112 114
Lysosomal Storage Disorders Hunters Syndrome 117 112 114
Lysosomal Storage Disorders Hurlers Syndrome 116 112 114
Lysosomal Storage Disorders Krabbes Disease 116 112 114
Lysosomal Storage Disorders Metachromatic Leukodystrophy 116 112 114
Lysosomal Storage Disorders Niemann-Pick Disease 116 112 114
Lysosomal Storage Disorders Tay Sachs Disease 116 112 114
Vitamins Beriberi Thiamine Deficiency 95 90 92
Vitamins Biotin 98 92 93
Vitamins Folate Deficiency 382 354 384
Vitamins Niacin 96 91 93
Vitamins Riboflavin 95 91 92
Vitamins Thiamine 95 90 92
Bio
che
mis
try
Ge
ne
tics
Me
tab
olis
mN
utr
itio
n
Vitamins Vitamin A Function and Deficiency 95 90 92
Vitamins Vitamin A Toxicity 95 90 92
Vitamins Vitamin B12 97 93 94
Vitamins Vitamin B12 Deficiency Causes 97 93 94
Vitamins Vitamin B5 96 91 93
Vitamins Vitamin B6 96 91 93
Vitamins Vitamin B6 Deficiency 96 91 93
Vitamins Vitamin C 98 94 95
Vitamins Vitamin D Deficiency 99 94 95
Vitamins Vitamin D Mechanism 99 94 95
Vitamins Vitamin D Toxicity 99 94 95
Vitamins Vitamin E Deficiency 99 94 96
Vitamins Vitamin K 99 95 96
Vitamins Wernicke Korsakoff 95 90 92
Vitamins Zinc Deficiency 99 95 96
Cellular Metabolism MBAerobic Respiration 99 101
Cellular Metabolism MBAnaerobic Respiration 99 101
Cellular Metabolism MBEnergy Accounting 99 101
Cellular Metabolism MBOxidative Phosphorylation 102 104
Enzymes MBCompetitive Inhibition 229 242
Enzymes MBEnzyme Types
Enzymes MBNon-Competitive Inhibition 229 242
Molecular Genetics MBChromosome Components 64 66
Molecular Genetics MBChromosome Forms
Molecular Genetics MBCodons 72-77 72
Molecular Genetics MBDNA Base Pairing 64 66
Molecular Genetics MBDNA Replication 68 69
Molecular Genetics MBEukaryotic Post Transcriptional Modification 71-77 73
Molecular Genetics MBEukaryotic Transcription Regulation 70 72
Molecular Genetics MBNucleus
Molecular Genetics MBRNA 70 72
Molecular Genetics MBTranscription Mechanism 70 72
Molecular Genetics MBTranslation Elongation 73 75
Molecular Genetics MBTranslation Mechanism 71-77 73
Reproduction MBAnaphase 74 76
Reproduction MBCell Life Cycle 74 76
Reproduction MBMetaphase 74 76
Reproduction MBOogenesis 522 569
Reproduction MBProphase 74 76
Reproduction MBSpermatogenesis 518 572
Reproduction MBTelophase 74 76
Heart Disorders Bacterial Endocarditis 301 274 292
Heart Disorders Dilated Cardiomyopathy 299 272 290
Heart Disorders Restrictive Cardiomyopathy 299 272 290
Heart Disorders Rheumatic Fever 302 274 292
Vascular Disorders Buerger’s Disease 304 276 296
Vascular Disorders Churg Strauss Syndrome 304 277 297
Vascular Disorders Henoch-Schonlein Purpura 305 277 297
Vascular Disorders Kawasaki Disease 304 276 296
Nu
trit
ion
Mo
lecu
lar
Bio
log
yB
ioch
em
istr
y
Pat
ho
log
y
Car
dio
vasc
ula
r Sy
ste
m
Vascular Disorders Microscopic Polyangiitis 304 277 296
Vascular Disorders Polyarteritis Nodosa 304 276 296
Vascular Disorders Takayasus Arteritis 304 276 296
Vascular Disorders Temporal Arteritis 304 276 296
Vascular Disorders Wegeners Characteristics 304 277 296
Vascular Disorders Wegeners Symptoms 304 277 296
Baby Circulatory †Fetal Circulation 132 252 265
Baby Circulatory † Postnatal Circulation 132 252 265
Cardiac Pharmacology Bile Acid Resin 308 281 300
Cardiac Pharmacology Class I Antiarrhythmics (Na+ Channel Blockers) Overview
310 283 302
Cardiac Pharmacology Class IA Antiarrhythmics (Na+ Channel Blockers) 310 283 302
Cardiac Pharmacology Class IB Antiarrhythmics (Na+ Channel Blockers) 310 283 302
Cardiac Pharmacology Class IC Antiarrhythmics (Na+ Channel Blockers) 310 283 302
Cardiac Pharmacology Class III Antiarrhythmics (K+ Channel Blockers) 311 284 303
Cardiac Pharmacology Class IV Antiarrhythmics (Ca2+ Channel Blockers) 312 284 304
Cardiac Pharmacology Digoxin Mechanism and Indication 309 282 301
Cardiac Pharmacology Digoxin Toxicity 309 282 301
Cardiac Pharmacology Ezetimibe 308 281 300
Cardiac Pharmacology Fibrates 308 281 300
Cardiac Pharmacology Hydralazine 306 279 298
Cardiac Pharmacology Niacin Therapy 308 281 300
Cardiac Pharmacology Nitroglycerin 306 280 299
Cardiac Pharmacology Nitroprusside 306 279 298
Cardiac Pharmacology Statins 308 281 300
Circulatory System MBCardiac Cycle - Diastole 256 270
Circulatory System MBCardiac Cycle - Systole 256 270
Circulatory System MBLymphatics 192 196
Heart Murmurs Aortic Regurgitation 285 259 273
Heart Murmurs Aortic Stenosis 285 259 273
Heart Murmurs Mitral Regurgitation 285 259 273
Heart Murmurs Mitral Stenosis 285 259 273
Heart Murmurs Patent Ductus Arteriosus 285 259 273
Heart Murmurs Tricuspid Regurgitation 285 259 273
Multiple Endocrine Neoplasia MEN 1 332 304 329
Multiple Endocrine Neoplasia MEN 2A 332 304 329
Multiple Endocrine Neoplasia MEN 2B 332 304 329
Congenital Adrenal Hyperplasias 11 Beta Hydroxylase Deficiency 318 291 312
Congenital Adrenal Hyperplasias 17 Alpha Hydroxylase Deficiency 318 291 312
Congenital Adrenal Hyperplasias 21 Hydroxylase Deficiency 318 291 312
Endocrine Basics MBAdrenal Glands 286 306
Endocrine Basics MBAnterior Pituitary 287 307
Endocrine Basics MBHypothalamus 289 309
Endocrine Basics MBPancreas 287 307
Endocrine Basics MBParathyroid Gland 293 314
Endocrine Basics MBPeptide Hormones
Endocrine Basics MBPosterior Pituitary 287 307
Endocrine Basics MBSteroid Hormones 295 316
Endocrine Basics MBTestes 516 564
Car
dio
vasc
ula
r Sy
ste
m
Em
bry
-o
log
yP
hys
iolo
gy
Pat
ho
log
yP
har
mac
olo
gy
Pat
ho
log
y P
hys
iolo
gy
En
do
crin
e S
yste
m
*-Updated Card †-New Card MB-Med Basic CS-Coming Soon
βα
Endocrine Basics MBThyroid Gland 295 316
GI Disorders Acute Gastritis 354 327 351
GI Disorders Carcinoid Syndrome 359 304 329
GI Disorders Chronic Gastritis 354 327 351
GI Disorders Crohn’s Disease Characteristics 355 328 354
GI Disorders Chron’s Symptoms and Associations 355 328 354
GI Disorders Hemochromatosis Characteristics 364 337 365
GI Disorders Hemochromatosis Symptoms 364 337 365
GI Disorders Hirschsprung Disease 357 330 356
GI Disorders Meckels Diverticulum 357 330 356
GI Disorders Stomach Cancer 354 327 351
GI Disorders Ulcerative Colitis Association 355 328 354
GI Disorders Ulcerative Colitis Characteristics 355 328 354
GI Disorders Wilson Pathophysiology 364 337 365
GI Disorders Wilson Symptoms 364 337 365
GI Pharmacology H2 Blocker Side Effects 368 341 371
GI Pharmacology H2
Blockers 368 341 371
GI Pharmacology Metoclopramide 370 342 372
GI Pharmacology Octreotide 368 341 371
GI Pharmacology Ondansetron 369 342 372
GI Pharmacology Proton Pump Inhibitors (PPIs) 368 341 371
Gastrointestinal Physiology Basics MBLarge Intestines 311 337
Gastrointestinal Physiology Basics MBOral Cavity
Gastrointestinal Physiology Basics MBSmall Intestine Absorption 322 348
Gastrointestinal Physiology Basics MBSmall Intestine Digestion 311 337
Gastrointestinal Physiology Basics MBStomach 321 346
Anemias β Thalassemia 381 353 383
Anemias Anemia Lab Value 385 357 387
Anemias Iron Deficiency Anemia 380 352 382
Anemias Sickle Cell Anemia (Management) 384 356 386
Anemias Sickle Cell Anemia (Mechanism) 384 356 386
Anemias Sickle Cell Anemia (Signs and Complications) 384 256 386
Leukemias Acute Lymphoblastic Leukemia 392 364 394
Leukemias Acute Myelogenous Leukemia 393 365 395
Leukemias Chronic Lymphocytic Leukemia 392 364 394
Leukemias Chronic Myelogenous Leukemia 393 365 395
Leukemias Hairy Cell Leukemia 392 364 394
Lymphomas Adult T Cell Lymphoma 390 362 392
Lymphomas Burkitts Lymphoma 390 362 392
Lymphomas Diffuse Large B Cell Lymphoma 390 362 392
Lymphomas Follicular Lymphoma 390 362 392
Lymphomas Hodgkins Lymphoma Characteristics 389 361 391
Lymphomas Hodgkins Lymphoma Symptoms 389 361 391
Lymphomas Mantle Cell Lymphoma 390 362 392
Mixed Platelet and Coagulation Disorders (DIC) Disseminated Intravascular Coagulation 388 360 390
Mixed Platelet and Coagulation Disorders Von Willebrand Disease 388 360 390
Myeloma Multiple Myeloma Pathophysiology 391 363 393
Myeloma Multiple Myeloma Symptoms 391 363 393
Pat
ho
log
yP
har
mac
olo
gy
Gas
tro
inte
stin
al S
yste
m
Ph
ysio
log
y
He
mat
olo
gy
& O
nco
log
y
Pat
ho
log
y
Platelet Disorders Hemolytic Uremic Syndrome (HUS) 163 135 139
Platelet Disorders Heparin Induced Thrombocytopenia (HIT) 395 367 398
Hematology & Oncology Pharmacology Heparin Indications 395 367 398
Hematology & Oncology Pharmacology Heparin Mechanisms 395 367 398
Hematology & Oncology Pharmacology Methotrexate 399 371 403
Hematology & Oncology Pharmacology Warfarin 395 367 399
Hematology Basics MBBlood Composition 344 374
Hematology Basics MBClotting 348 377
Hematology Basics MBHemoglobin 547 597
Autoimmune Disorders † Sjögren’s Syndrome 418 391 425
Autoimmune Disorders † Systemic Lupus Erythematosus (SLE) Diagnosis and Clinical Features
421 393 427
Autoimmune Disorders † Systemic Lupus Erythematosus (SLE) Mechanism, Treatment and Complications
421 393 427
B and T Cell Disorders Ataxia Telangiectasia 238 207 213
B and T Cell Disorders Hyper IgM Syndrome 237 207 213
B and T Cell Disorders Severe Combined Immunodeficiency 238 207 213
B and T Cell Disorders Wiskott Aldrich 238 207 213
B Cell Disorders Bruton’s Agammaglobulinemia 237 206 212
B Cell Disorders Common Variable Immunodeficiency 237 206 212
B Cell Disorders Selective IgA Deficiency 237 206 212
Phagocyte Disorders Chediak-Higashi Syndrome 238 207 213
Phagocyte Disorders Chronic Granulomatous Disease 238 207 213
Phagocyte Disorders Leukocyte Adhesion Deficiency 238 207 213
T Cell Disorders Chronic Mucocutaneous Candidiasis 237 206 212
T Cell Disorders Hyper IgE Syndrome 237 206 212
T Cell Disorders IL12 Receptor Deficiency 237 206 212
T Cell Disorders Thymic Aplasia 237 89 212
Immune System Basics MBCell-mediated Adaptive Immune Response 195 199
Immune System Basics MBHumoral Adaptive Immunity 193 198
Immune System Basics MBImmune System Tissues 192 196
Immune System Basics MBInflammatory Response 212 220
Immune System Basics MBInnate Immunity Barriers
Immune System Basics MBInnate Immunity Cellular Response 193 198
High Yield † Ankylosing Spondylitis 392 426
High Yield CS Anticentromere Antibodies 423 395 430
High Yield CS Anti-desmoglein Antibodies 609 570 620
High Yield CS Anti-glomerular Basement Membrane Antibodies
585 570 620
High Yield CS Antihistone Antibodies 585 570 620
High Yield † Auer Rods 393 365 395
High Yield † C. Diff Treatment 574 624
High Yield † Ghon Complex 132 134
High Yield † H. Pylori Associations 577 627
High Yield CS Hereditary Spherocytosis Features 356 386
High Yield CS Hereditary Spherocytosis Management 356 386
High Yield † HLA-B27 Associations 194 199
High Yield CS Hypertrophic Cardiomyopathy Mechanism 272 290
Imm
un
olo
gy
Ph
arm
aco
log
yIm
mu
ne
Re
spo
nse
sP
hys
iolo
gy
Imm
un
e S
yste
m
Bas
ics
Hig
h Y
ield
Pat
ho
log
yH
em
ato
log
y &
On
colo
gy
High Yield CS Hypertropic Cardiomyopathy Signs/Symptoms and Treatment
272 290
High Yield † Lewy Bodies 571 621
High Yield † Peutz-Jaghers Syndrome 358 331 358
High Yield † Plummer-Vinson Syndrome 351 324 350
High Yield CS Sheehan’s Syndrome 301 326
High Yield CS Tamoxifen 374 406
High Yield † Waterhouse-Friderichs en Syndrome 297 318
Gram Negative Bacteria Bacteroides Fragilis 149 167 170
Gram Negative Bacteria Bartonella Henselae 167 139 142
Gram Negative Bacteria Bordetella Pertussis 147 124 126
Gram Negative Bacteria Borrelia Burgdorferi 165 137 141
Gram Negative Bacteria Brucella 167 139 142
Gram Negative Bacteria Campylobacter Jejuni 164 136 140
Gram Negative Bacteria Chlamydia Characteristics 169 141 145
Gram Negative Bacteria Chlamydia Trachomatis 169 141 145
Gram Negative Bacteria Coxiella Burnetti 168 139 144
Gram Negative Bacteria E. Coli 163 135 139
Gram Negative Bacteria EHEC 163 135 139
Gram Negative Bacteria Francisella Tularensis 167 139 142
Gram Negative Bacteria Haemophilus Ducreyi 201 173 176
Gram Negative Bacteria Haemophilus Influenzae Characteristics 162 134 137
Gram Negative Bacteria Haemophilus Influenzae Disease 162 134 137
Gram Negative Bacteria Helicobactor Pylori 164 137 140
Gram Negative Bacteria Klebsiella Disease 163 136 139
Gram Negative Bacteria Klebsiella Characteristics 163 136 139
Gram Negative Bacteria Neisseria Gonorrhea Characteristics 162 134 137
Gram Negative Bacteria Neisseria Gonorrhea Symptoms 162 134 137
Gram Negative Bacteria Neisseria Meningitidis 162 134 137
Gram Negative Bacteria Pseudomonas Characteristics 163 135 138
Gram Negative Bacteria Pseudomonas Symptoms 163 135 138
Gram Negative Bacteria Rickettsia 168 140 144
Gram Negative Bacteria Rocky Mountain Spotted Fever 168 139 144
Gram Negative Bacteria Salmonella Enteritidis 164 136 139
Gram Negative Bacteria Salmonella Typhi 164 136 139
Gram Negative Bacteria Shigella 164 136 139
Gram Negative Bacteria Syphilis 166 138 141
Gram Negative Bacteria Vibrio Cholera Characteristics 164 136 140
Gram Negative Bacteria Vibrio Cholera Disease 164 136 140
Gram Negative Bacteria Yersinia Enterocolitica 164 136 140
Gram Negative Bacteria Yersinia Pestis 167 139 142
Gram Positive Bacteria Actinomyces Israeli 159 131 134
Gram Positive Bacteria Clostridium Botulinum 158 124 132
Gram Positive Bacteria Clostridium Difficile 158 130 132
Gram Positive Bacteria Clostridium Perfringens 158 125 132
Gram Positive Bacteria Clostridium Tetani 158 124 132
Gram Positive Bacteria Corynebacterium Diphtheria 157 130 132
Gram Positive Bacteria Enterococci 157 129 131
Gram Positive Bacteria Listeria Disease 159 131 133
Bac
teri
olo
gy
Hig
h Y
ield
Mic
rob
iolo
gy
Pat
ho
log
y
Gram Positive Bacteria Listeria Monocytogenes 159 131 133
Gram Positive Bacteria Mycobacterium Tuberculosis 159 132 135
Gram Positive Bacteria Mycobacterium Leprae 159 133 135
Gram Positive Bacteria Nocardia 147 131 134
Gram Positive Bacteria Staph Aureus Characteristics 156 128 130
Gram Positive Bacteria Staph Aureus Disease 156 128 130
Gram Positive Bacteria Staph Epidermidis 156 128 130
Gram Positive Bacteria Staph Saprophyticus 156 122 130
Gram Positive Bacteria Streptococcus Agalactiae 157 129 131
Gram Positive Bacteria Streptococcus Pneumoniae Characteristics 156 128 130
Gram Positive Bacteria Streptococcus Pneumoniae Disease 156 128 130
Gram Positive Bacteria Streptococcus Pyogenes Characteristics 157 129 131
Gram Positive Bacteria Streptococcus Pyogenes Disease 157 129 131
Gram Positive Bacteria Streptococcus Viridans 156 128 131
Gram (Other) Gardnerella Vaginalis 167 139 143
Gram (Other) Legionella Characteristics 162 135 138
Gram (Other) Legionella Symptoms 162 135 138
Gram (Other) Mycoplasma Pneumoniae 170 142 145
Fungi Basics Fungi Facts
Opportunistic Mycoses Aspergillus Fumigates 173 145 148
Opportunistic Mycoses Candida Albicans 173 145 148
Opportunistic Mycoses Cryptococcus Neoformans 173 145 148
Opportunistic Mycoses Mucor Rhizopus 173 145 148
Opportunistic Mycoses Pneumocystis Jiroveci 174 146 149
Opportunistic Mycoses Sporothrix Schenckii 174 146 149
Systemic and Skin Mycoses Blastomyces 171 143 146
Systemic and Skin Mycoses Coccidioidomycosis 171 143 146
Systemic and Skin Mycoses Histoplasmosis 171 143 146
Systemic and Skin Mycoses Paracoccidioido - Mycosis 171 143 146
Systemic and Skin Mycoses Tinea Versicolor 172 144 147
Protozoa Babesia 176 149 152
Protozoa Cryptosporidium 175 147 150
Protozoa Entamoeba Histolytica 175 147 150
Protozoa Giardia Lamblia 175 147 150
Protozoa Plasmodium General 176 149 152
Protozoa Plasmodium Specific 176 149 152
Protozoa Toxoplasma Gondii 176 148 151
Protozoa Trichomonas Vaginalis 177 150 153
Protozoa Trypanosoma Brucei 176 148 151
Protozoa Trypanosoma Cruzi 177 150 153
Anti TB Drugs Ethambutol 212 183 187
Anti TB Drugs Isoniazid 212 183 187
Anti TB Drugs Rifampin 212 183 187
Antibiotics 1st Generation Cephalosporin 206 178 181
Antibiotics 2nd Generation Cephalosporin 206 178 181
Antibiotics 3rd Generation Cephalosporin 206 178 181
Antibiotics 4th Generation Cephalosporin 206 178 181
Antibiotics Aminoglycosides 209 180 184
Antibiotics Aminopenicillin Mechanism 205 177 180
Mic
rob
iolo
gy
Bac
teri
olo
gy
Myc
olo
gy
Par
asit
olo
gy
Ph
arm
aco
log
y
Antibiotics Aminopenicillin Uses 205 177 180
Antibiotics Antipseudomonal Penicillins 205 177 180
Antibiotics Aztreonam 206 178 181
Antibiotics Beta Lactamase Inhibitors 205 177 180
Antibiotics Cephalosporin 206 178 181
Antibiotics Chloramphenicol 210 181 185
Antibiotics Clindamycin 210 181 185
Antibiotics Fluoroquinolones Antibiotics 211 182 186
Antibiotics Fluoroquinolones Toxicities 211 182 186
Antibiotics Imipenem 207 178 182
Antibiotics Macrolides 209 180 184
Antibiotics Macrolides Toxicities 209 180 184
Antibiotics Metronidazole 211 182 187
Antibiotics Penicillin 204 176 179
Antibiotics Polymyxins 204 120 122
Antibiotics Protein Synthesis Inhibitors 208 179 183
Antibiotics Sulfa Drug Allergies 273 242 255
Antibiotics Sulfonamides Mechanisms 210 181 185
Antibiotics Sulfonamides Toxicites 210 181 185
Antibiotics Tetracycline Drugs and Uses 209 180 184
Antibiotics Tetracycline Mechanism 209 180 184
Antibiotics Tetracycline Toxicites 209 180 184
Antibiotics Trimethoprim 211 182 186
Antibiotics Vancomycin Mechanism 207 179 182
Antibiotics Vancomycin Toxicity 207 179 182
TORCHES CMV TORCH 199 171 174
TORCHES Rubella TORCH 199 171 174
TORCHES Syphilis TORCH 199 171 174
TORCHES Toxoplasma Gondii TORCH 199 171 174
DNA Virus Adenovirus 183 155 158
DNA Virus Cytomegalovirus 184 156 159
DNA Virus Epstein Barr Virus 185 157 159
DNA Virus Epstein Barr Virus Mononucleosis 185 157 159
DNA Virus Hepatitis B Virus Characteristics 190 162 165
DNA Virus Hepatitis B Virus Disease 190 162 165
DNA Virus Herpes Simplex Virus 184 156 159
DNA Virus Human Papillomavirus 183 155 158
DNA Virus Parvovirus 183 155 158
DNA Virus Polyomavirus 183 155 158
DNA Virus Pox Virus 183 155 158
DNA Virus Roseola 184 172 175
DNA Virus Varicella Zoster 184 156 159
RNA Virus Coxsackie Virus 186 172 175
RNA Virus Hepatitis A 190 162 165
RNA Virus Hepatitis C 190 162 165
RNA Virus HIV CD 100 194 165 168
RNA Virus HIV CD 200 194 165 168
RNA Virus HIV CD 400 194 165 168
RNA Virus HIV CD 50 194 165 168
Ph
arm
aco
log
y
Mic
rob
iolo
gy
Syst
em
sV
iro
log
y
RNA Virus Influenza Virus 188 160 163
RNA Virus Mumps 189 161 164
RNA Virus Parainfluenza 188 160 161
RNA Virus Paramyxovirus 188 160 161
RNA Virus Picornavirus 187 159 162
RNA Virus Rabies Symptoms and Animals 190 162 165
RNA Virus Rabies Virus 190 162 165
RNA Virus Rhinovirus 187 159 162
RNA Virus Rotavirus 187 159 162
RNA Virus Rubella 188 160 163
RNA Virus Rubeola 189 161 175
RNA Virus Yellow Fever Virus 187 159 162
Dermatology Basics MBSkin Anatomy 378 410
Dermatology Basics MBSkin Functions
Brachial Plexus † Brachial Plexus Roots 408 381 413
Brachial Plexus † Brachial Plexus Trunks 408 381 413
Brachial Plexus † Brachial Plexus Divisions 408 381 413
Brachial Plexus † Brachial Plexus Cords 408 381 413
Brachial Plexus † Brachial Plexus Branches 408 381 413
Bone Tumors Chondrosarcoma 416 389 423
Bone Tumors Ewing’s Sarcoma 416 389 422
Bone Tumors Giant Cell Tumor 416 389 422
Bone Tumors Osteosarcoma 416 389 422
Musculoskeletal System Basics MBMacroscopic Bone Structure 386 419
Musculoskeletal System Basics MBMuscle Types 385 417
Musculoskeletal System Basics MBSkeletal Muscle Contraction Action 386 417
Musculoskeletal System Basics MBSkeletal Muscle Contraction Initiation 385 417
Brain Tumors Craniopharyngioma 470 448 489
Brain Tumors Ependymoma 470 448 489
Brain Tumors Glioblastoma Multiforme 469 447 488
Brain Tumors Hemangioblastoma 470 448 488
Brain Tumors Medulloblastoma 470 448 489
Brain Tumors Meningioma 469 447 488
Brain Tumors Oligodendroglioma 469 447 488
Brain Tumors Pilocytic Astrocytoma 470 448 489
Brain Tumors Pinealoma 455 433 471
Brain Tumors Prolactinoma 469 301 324
Brain Tumors Schwannoma 469 447 488
Brain Vasculature Circle of Willis 443 423 458
Effects of Strokes Middle Cerebral Artery 444 422 460
Effects of Strokes Anterior Cerebral Artery 444 422 460
Neurocutaneous Disorders Neurofibromatosis Type 1 467 446 487
Neurocutaneous Disorders Neurofibromatosis Type 2 467 446 487
Neurocutaneous Disorders Sturge Weber Syndrome 467 278 487
Neurocutaneous Disorders Tuberous Sclerosis 467 85 487
Neurocutaneous Disorders Von Hippel Lindau Disease 467 85 87
Autonomic Pharmacology α Agonists 266 235 249
Autonomic Pharmacology α2 Agonists (Sympathoplegics) 267 236 249
Mic
rob
iolo
gy
Vir
olo
gy
Ph
ysio
l-o
gy
De
rma-
tolo
gy
Ph
ysio
log
y
Mu
scu
losk
ele
tal S
yste
m
Pat
ho
log
yP
ath
olo
gy
Ne
rvo
us
Syst
em
An
ato
my
Autonomic Pharmacology β1 Agonists 266 235 248
Autonomic Pharmacology β2 Agonists 267 235 248
Autonomic Pharmacology Anticholinergics 266 234 247
Autonomic Pharmacology Anticholinergics Continued 234 247
Autonomic Pharmacology Anticholinergics Inhibitor Poisoning 265 233 246
Autonomic Pharmacology Atropine 266 234 247
Autonomic Pharmacology Cardiovascular Effects of β Blockers 269 238 251
Autonomic Pharmacology Direct Cholinomimetics 265 233 246
Autonomic Pharmacology Ephedrine 267 235 248
Autonomic Pharmacology Epinephrine 266 235 248
Autonomic Pharmacology Indirect Cholinomimetics 265 233 246
Autonomic Pharmacology Nonselective α Blockers 268 237 250
Autonomic Pharmacology Nonselective β Blockers 269 238 251
Autonomic Pharmacology Norepinephrine 266 235 248
Autonomic Pharmacology Phenylephrine 577 235 248
Autonomic Pharmacology Selective α1 Blockers 268 237 250
Autonomic Pharmacology Selective α2 Blockers 268 237 250
Autonomic Pharmacology Selective β1 Blockers 269 238 251
Autonomic Pharmacology Systemic Effects of β Blockers 263 231 251
Neurological Pharmacology Barbiturates 476 452 493
Neurological Pharmacology Benzodiazepines Overview 475 453 493
Neurological Pharmacology Butorphanol 472 449 491
Neurological Pharmacology Carbamazepine 473 451 492
Neurological Pharmacology Donepezil 479 456 496
Neurological Pharmacology Ethosuximide 473 451 492
Neurological Pharmacology Gabapentin 473 451 492
Neurological Pharmacology Inhaled Anesthetics 453 494
Neurological Pharmacology IV Anesthetics 476 454 494
Neurological Pharmacology Lamotrigine 473 451 492
Neurological Pharmacology Levodopa/Carbidopa 478 456 496
Neurological Pharmacology Local Anesthetic Overview 477 454 495
Neurological Pharmacology Memantine 479 456 496
Neurological Pharmacology Nonbenzodiazepine Hypnotics 475 453 493
Neurological Pharmacology Nondepolarizing Neuromuscular Blocking Drugs 477 455 495
Neurological Pharmacology Opioids 471 449 490
Neurological Pharmacology Parkinson’s Drugs 478 455 496
Neurological Pharmacology Phenytoin 474 452 492
Neurological Pharmacology Succinylcholine 477 455 495
Neurological Pharmacology Sumatriptan 479 456 497
Neurological Pharmacology Topiramate 473 451 492
Neurological Pharmacology Tramadol 472 450 491
Neurological Pharmacology Valproic Acid 473 452 492
Cranial Nerves CN I 456 434 472
Cranial Nerves CN II 456 434 472
Cranial Nerves CN III 456 434 472
Cranial Nerves CN IV 456 434 472
Cranial Nerves CN V 456 434 472
Cranial Nerves CN VI 456 434 472
Ne
rvo
us
Syst
em
Ph
arm
aco
log
yP
hys
iolo
gy
Cranial Nerves CN VII 456 434 472
Cranial Nerves CNVIII 456 434 472
Cranial Nerves CN IX 456 434 472
Cranial Nerves CN X 456 434 472
Cranial Nerves CN XI 456 434 472
Cranial Nerves CN XII 456 434 472
Cranial Nerves Cranial Nerve Function 434 472
Nervous System Basics MBAutonomic Nervous System 435
Nervous System Basics MBCentral Nervous System 418 455
Nervous System Basics MBChemical Synapse
Nervous System Basics MBElectrical Synapse
Nervous System Basics MBEye 437 476
Nervous System Basics MBNeuron Action Potential Initiation 411 448
Nervous System Basics MBNeuron Action Potential Propagation 411 448
Nervous System Basics MBNeuron Resting Potential
Nervous System Basics MBSomatic Reflex Arc 230 243
Biostatistics Sensitivity 53 51 51
Biostatistics Specificity 53 51 51
Early Developmental Milestones 2 Months 62 59 62
Early Developmental Milestones 4 Months 62 59 62
Early Developmental Milestones 6 Months 62 59 62
Early Developmental Milestones 9 Months 62 59 62
Early Developmental Milestones 1 Year 62 59 62
Early Developmental Milestones 18 Months 62 59 62
Early Developmental Milestones 2 Years 62 59 62
Early Developmental Milestones 3 Years 62 59 62
Early Developmental Milestones 4 Years 62 59 62
P450 Interactions P450 Inducer 273 242 255
P450 Interactions P450 Inhibitor 273 242 255
Toxicities Acetaminophen Toxicity 270 239 252
Toxicities Actylcholinesterase Inhibitor Toxicity 270 239 252
Toxicities Amphetamine Toxicity 270 239 252
Toxicities Antimuscarinic Toxicity 270 239 252
Toxicities Arsenic Copper God Toxicity 270 239 252
Toxicities Benzodiazepine Toxicity 270 239 252
Toxicities Beta Blocker Toxicity 270 239 252
Toxicities Iron Toxicity 270 239 252
Toxicities Lead Toxicity 270 239 252
Toxicities Opioid Toxicity 270 239 252
Toxicities Tricyclics Anti-Depressant Toxicity 270 239 252
Toxicities Warfarin Toxicity 270 239 252
G Protein Coupled Receptors Alpha 1 Receptors 263 231 244
G Protein Coupled Receptors Alpha 2 Receptors 263 231 244
G Protein Coupled Receptors Beta 1 Receptors 263 231 244
G Protein Coupled Receptors Beta 2 Receptors 263 231 244
Homeostasis Basics MBBlood Acid-Base Control 487 532
Homeostasis Basics MBHigh Blood Pressure Response 263 279
Homeostasis Basics MBLow Blood Pressure Response 483 528
Ne
rvo
us
Syst
em
Ph
ysio
log
y
Soci
al &
Be
hav
iora
l Sci
en
ce
Sid
e E
ffe
cts
Ph
arm
aco
log
y
Au
ton
om
ic
Dru
gs
Ho
me
ost
asis
Nephritic Syndromes Alport Syndrome 516 79 538
Nephritic Syndromes Berger’s Disease 516 492 538
Nephritic Syndromes Nephritic Syndrome 516 492 538
Nephritic Syndromes Post Streptococcal Glomerulonephritis 516 492 538
Nephritic Syndromes Rapidly Progressive Glomerulonephritis 516 492 538
Nephrotic Syndromes Amyloidosis 517 217 536
Nephrotic Syndromes Diabetic Glomerulonephropathy 518 491 537
Nephrotic Syndromes Focal Segmental Glomerulosclerosis 517 490 536
Nephrotic Syndromes Membranoproliferative Glomerulonephritis 518 491 537
Nephrotic Syndromes Membranous Glomerulonephritis 517 490 536
Nephrotic Syndromes Minimal Change Disease 517 490 536
Nephrotic Syndromes Nephrotic Syndrome 517 490 536
Renal Pharmacology ACE Inhibitor Toxicity 527 502 549
Renal Pharmacology ACE Inhibitors 527 502 549
Renal Pharmacology Acetazolamide 525 500 547
Renal Pharmacology Angiotensin Receptor Blockers (ARBs) 510 485 530
Renal Pharmacology K+ Sparing Diuretics 526 501 548
Renal Pharmacology Loop Diuretics 525 500 547
Renal Pharmacology Mannitol 525 500 547
Renal Pharmacology Thiazide Diuretics 525 501 548
Acid & Base Disorders Anion Gap Metabolic Acidosis 514 488 533
Acid & Base Disorders Metabolic Alkalosis 514 487 532
Acid & Base Disorders Normal Gap Metabolic Acidosis 514 488 533
Acid & Base Disorders Respiratory Acidosis 514 487 532
Acid & Base Disorders Respiratory Alkalosis 514 487 532
Renal Basics MBCollecting Duct 483 524
Renal Basics MBDistal Tubule 483 524
Renal Basics MBExcretory Anatomy 479 528
Renal Basics MBLoop of Henle 483 524
Renal Basics MBProximal Tubule 483 524
Renal Basics MBRenal Corpuscle 479 528
Lung Diseases Asthma 568 554 604
Lung Diseases Bronchiectasis 568 554 604
Lung Diseases Chronic Bronchitis 568 554 604
Lung Diseases Emphysema 568 554 604
Lung Diseases Obstructive Lung Disease 568 554 604
Lung Diseases Restrictive Lung Disease 569 555 605
Lung Diseases Restrictive vs. Obstructive Lung Disease 568 556 604
Respiratory Calculations A-a Gradient 565 550 599
Respiratory Calculations Alveolar Gas Equation 565 550 599
Respiratory Calculations Physiologic Dead Space (VD) 562 546 596
Respiratory System Basics MBAlveolar Gas Exchange 544 594
Respiratory System Basics MBRespiratory Anatomy 544 594
Ovarian Tumors Brenner Tumor 547 532 582
Ovarian Tumors Choriocarcinoma 546 531 583
Ovarian Tumors Cystadenocarcinoma 547 532 583
Ovarian Tumors Cystadenoma 547 532 582
Ovarian Tumors Dysgerminoma 546 531 583
Re
nal
Sys
tem
Pat
ho
log
yP
har
mac
olo
gy
Ph
ysio
log
yP
ath
olo
gy
Re
spir
ato
ry S
yste
m
Ph
ysio
log
y
Re
pro
du
ctiv
e
Pat
ho
log
y
Ovarian Tumors Fibromas 547 532 582
Ovarian Tumors Granulosa Cell Tumor 547 532 583
Ovarian Tumors Krukenberg Tumor 547 532 583
Ovarian Tumors Teratoma 546 531 582
Ovarian Tumors Yolk Sac Tumor 546 531 583
Sex Disorders 5 Alpha Reductase Deficiency 540 525 575
Sex Disorders Androgen Insensitivity 540 525 575
Sex Disorders Klinefelter’s Syndrome 539 524 574
Sex Disorders Turner Syndrome 539 524 574
Psychiatric Pharmacology Antipsychotics Overview 498 473 517
Psychiatric Pharmacology Atypical Antipsychotics 498 473 517
Psychiatric Pharmacology Bupropion 501 476 520
Psychiatric Pharmacology Buspirone 499 474 518
Psychiatric Pharmacology CNS Stimulants 497 472 516
Psychiatric Pharmacology High Potency Antipsychotic Drugs 498 473 517
Psychiatric Pharmacology Lithium 499 474 518
Psychiatric Pharmacology Low Potency Antipsychotic Drugs 498 473 517
Psychiatric Pharmacology (MAO-I) Monoamine Oxidase Inhibitor Contraindications
500 475 519
Psychiatric Pharmacology (MAO-I) Monoamine Oxidase Inhibitors 500 475 519
Psychiatric Pharmacology Neuroleptic Malignant Syndrome 498 473 517
Psychiatric Pharmacology Selective Serotonin Reuptake Inhibitors (SSRI) Overview
500 475 519
Psychiatric Pharmacology Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
500 475 519
Psychiatric Pharmacology Trazodone 501 476 520
Psychiatric Pharmacology Tricyclic Antidepressant Drugs (TCAs) 500 475 519
Psychiatric Pharmacology Tricyclic Antidepressants (TCAs) Overview 500 475 519
Psy
chia
try
Ph
arm
aco
log
y
*-Updated Card †-New Card MB-Med Basic CS-Coming Soon
Re
pro
du
ctiv
e
Pat
ho
log
y
